2025
Pediatric thalamic incidentalomas: a retrospective analysis of their characteristics, evolution, management, and prognostic factors for progression
TABORSKA, Jana; Katarina HORCICAKOVA; Adela BUBENIKOVA; Jakub TABORSKY; Martin KYNCL et al.Základní údaje
Originální název
Pediatric thalamic incidentalomas: a retrospective analysis of their characteristics, evolution, management, and prognostic factors for progression
Autoři
TABORSKA, Jana; Katarina HORCICAKOVA; Adela BUBENIKOVA; Jakub TABORSKY; Martin KYNCL; Miroslav KOBLIZEK; David SUMERAUER; Michal ZAPOTOCKY; Zdeněk PAVELKA; Ondrej BRADAC a Vladimir BENES
Vydání
Acta neurochirurgica, Vienna, SPRINGER WIEN, 2025, 0001-6268
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Rakousko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.900 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/25:00143757
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Incidentaloma; Thalamus; Pediatric tumor; Follow-up; Prognostic factors
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 2. 2026 12:27, Mgr. Tereza Miškechová
Anotace
V originále
Purpose: The increasing availability of advanced neuroimaging has led to a rise in incidental findings among pediatric patients. Management strategies include immediate surgical intervention, observation or surgery upon progression. These are influenced by imaging characteristics, lesion behavior over time, patient/family preferences, and the lesion's surgical risks. The thalamus's eloquent location often warrants a more conservative approach. Identifying features predictive of growth could help inform clinical decisions regarding surveillance and potential intervention. Methods: We retrospectively analyzed 44 pediatric patients with 46 thalamic incidentalomas, assessing radiological characteristics, temporal changes, and factors predictive of progression. Progression was defined as a change in size and/or new/increased contrast enhancement. Prognostic factors for progression (demographics, initial tumor volume, extension beyond thalamus, changes in enhancement, margin characteristics) were assessed for significance. Results: Of 46 incidentalomas, 40 were followed longitudinally. Nine incidentalomas (22.5%) showed regression, while nine (22.5%) progressed. The average time to regression was 947 days, and to progression, 516 days. Three patients underwent biopsy due to progressive changes; each was diagnosed with low-grade glioma. Statistical analysis revealed that initial incidentaloma volume, extension beyond the thalamus, and contrast enhancement were significantly associated with progression (p = 0.025, p < 0.001, and p = 0.001, respectively). Conclusions: Most pediatric thalamic incidentalomas are small, stable, and likely low-grade. However, approximately one-fifth exhibit progressive features, warranting prolonged surveillance. Larger initial volume, extra-thalamic extension, and contrast enhancement are significant predictors of progression and may justify earlier intervention. Individualized management remains essential, balancing natural history with surgical risk.